Sunnyvale, CA (PRWEB) September 01, 2015
Molecular Devices today announced the launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative system fits a broad range of automated cell-based imaging applications, especially emerging assays that use 3D cellular models such as spheroids, tissues, and organisms.
The ImageXpress Micro Confocal features the revolutionary AgileOptix™ technology which enables simple, user-defined configurations to ensure maximum assay performance for both confocal and widefield imaging. Multiple confocal geometries are available including pinhole and slit confocal imaging–the only commercially available high-content imaging system with this option. Unlike other spinning disc confocal systems, AgileOptix technology enables the ImageXpress Micro Confocal to deliver the sensitivity and throughput needed for demanding applications by combining a powerful solid-state light engine, proprietary spinning disc technology, advanced optics and high-quantum efficiency scientific CMOS sensors. The system acquires >3 log dynamic range and captures publication-quality images while its large optical field of view maximizes collection of statistically-relevant data.
"We are very excited to introduce this innovative imaging system with breakthrough capabilities ideally suited for today’s complex, more physiologically relevant cellular applications” said Greg Milosevich, President of Molecular Devices. "With more than 30 years of experience developing high-performance solutions advancing protein and cell biology, we have designed this system to bring the power of confocal imaging to a much broader range of labs while building on the image quality, flexibility, and robustness of our ImageXpress family. This introduction strengthens our position as the leading provider of cell-based assay solutions by providing customers with a truly unique platform in the fast-growing area of complex, physiologically-relevant cellular models.”
About Molecular Devices, LLC
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.